Global Clinical Data Analytics Industry

Global Clinical Data Analytics Industry

  • September 2020 •
  • 144 pages •
  • Report ID: 5956299 •
  • Format: PDF
Global Clinical Data Analytics Market to Reach $35.5 Billion by 2027

Amid the COVID-19 crisis, the global market for Clinical Data Analytics estimated at US$5 Billion in the year 2020, is projected to reach a revised size of US$35.5 Billion by 2027, growing at aCAGR of 32.2% over the period 2020-2027. Cloud, one of the segments analyzed in the report, is projected to record 40.9% CAGR and reach US$28.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the On-Premise segment is readjusted to a revised 16.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.5 Billion, While China is Forecast to Grow at 29.9% CAGR

The Clinical Data Analytics market in the U.S. is estimated at US$1.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.7 Billion by the year 2027 trailing a CAGR of 30.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 28.8% and 25.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 20.9% CAGR.We bring years of research experience to this 6th edition of our report. The 144-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,
  • Athenahealth, Inc.
  • IBM Corporation
  • Intersystems
  • Koninklijke Philips NV
  • McKesson Corporation
  • MedeAnalytics, Inc.
  • Optum, Inc.
  • Oracle Corporation
  • Verisk Analytics, Inc.